• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS D-DIMER GEN.2; FIBRINOGEN/FIBRIN DEGRADATION PRODUCTS ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS D-DIMER GEN.2; FIBRINOGEN/FIBRIN DEGRADATION PRODUCTS ASSAY Back to Search Results
Model Number D-DIMER G2
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/20/2021
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Medwatch field udi number = (b)(4).
 
Event Description
The initial reporter stated they received discrepant results for 24 patient samples tested with the d-di tina-quant d-dimer gen.2 assay on a cobas pro c 503 analyzer.The results measured on the c 503 analyzer were lower when compared to values obtained using the biomerieux mini vidas d-dimer method.No incorrect results were reported outside of the laboratory.Refer to the attachment for all patient data.The serial number of the c 503 analyzer is (b)(4).
 
Manufacturer Narrative
The investigation could not identify a product problem.The difference in values between the roche d-dimer reagent and the competitor reagent is most likely due to the different specificity of the antibody used or other test characteristics.D-dimer is not a standardized analyte and results generated using different d-dimer assays are not necessarily identical due to factors such as (but not limited to): reactivity/specificity of different antibodies.Epitope expression during fibrin formation and degradation.Heterogeneity of the fibrin degradation products in plasma.Calibrator material.Variation in optical detection ability between different instruments.Assay formats (latex bead size and required wavelengths).Interference by other analytes (e.G.Rheumatoid factor , mouse monoclonal antibodies).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
D-DIMER GEN.2
Type of Device
FIBRINOGEN/FIBRIN DEGRADATION PRODUCTS ASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11517423
MDR Text Key266064354
Report Number1823260-2021-00852
Device Sequence Number1
Product Code GHH
Combination Product (y/n)N
PMA/PMN Number
K062203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Model NumberD-DIMER G2
Device Catalogue Number08105626190
Device Lot Number51764401
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/26/2021
Initial Date FDA Received03/18/2021
Supplement Dates Manufacturer Received02/26/2021
Supplement Dates FDA Received04/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-